Lirafit Solution For Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Lirafit Solution For Injection
contains Liraglutide 6mg/mL, manufactured by Glenmark. Liraglutide is a GLP-1 receptor agonist administered once daily by subcutaneous injection, indicated for chronic weight management and type 2 diabetes. As the daily-injection alternative to weekly semaglutide products, it offers proven weight loss of 5–8% with the SCALE clinical trial evidence base. Glenmark's manufacturing ensures pharmaceutical-grade consistency.
Benefits:
- Proven 5–8% body weight reduction in the SCALE obesity trial (Saxenda equivalent)
- Daily GLP-1 dosing provides consistent 24-hour appetite suppression throughout the day
- Also approved for type 2 diabetes at 1.2mg and 1.8mg doses (Victoza equivalent)
- Manufactured by Glenmark — India's established globally certified pharmaceutical company
- Affordable daily-injection liraglutide for sustained weight management
How It Works:
Liraglutide binds to GLP-1 receptors in the hypothalamus and brainstem, reducing appetite and caloric intake. Simultaneously, it slows gastric emptying to prolong post-meal satiety and enhances glucose-dependent insulin secretion from the pancreas. Unlike weekly semaglutide, daily liraglutide injections maintain steady-state drug levels throughout the day for continuous appetite control.
Composition:
- Liraglutide: 6mg per mL solution
Dosage and Administration:
Begin at 0.6mg once daily for 1 week. Increase to 1.2mg in week 2. For weight management (Saxenda equivalent), advance to 1.8mg, 2.4mg, and then 3mg over subsequent weeks. For type 2 diabetes, 1.2mg or 1.8mg once daily. Inject subcutaneously into the abdomen, thigh, or upper arm at any time of day.
Side Effects:
Common: nausea, diarrhoea, constipation, vomiting, decreased appetite, headache, dizziness. Uncommon: elevated resting heart rate, injection-site reactions. Serious: pancreatitis, gallbladder disease, thyroid C-cell tumours.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Use with caution in renal or hepatic impairment. Monitor for suicidal ideation (reported in some GLP-1 trials). Not recommended during pregnancy.
Frequently Asked Questions
Q1: What is Lirafit used for?
Lirafit Solution For Injection contains liraglutide 6mg/mL by Glenmark, used for chronic weight management (at 3mg daily) and type 2 diabetes (at 1.2–1.8mg daily). It is a once-daily GLP-1 receptor agonist equivalent to Saxenda and Victoza.
Q2: How does Lirafit (liraglutide) compare to semaglutide products?
Liraglutide requires daily injection versus semaglutide's once-weekly dose. Semaglutide generally produces greater weight loss (10–15% vs 5–8%) due to its longer half-life and stronger GLP-1 receptor binding. Lirafit is a well-established option for patients who prefer or require a shorter-acting daily GLP-1 agonist.
Q3: How much weight loss can I expect on Lirafit 3mg?
The SCALE Obesity trial demonstrated approximately 8% average body weight reduction over 56 weeks with liraglutide 3mg versus placebo, alongside diet and exercise. Individual results vary based on adherence, diet, and physical activity.
Q4: Is Lirafit the same as Saxenda?
Lirafit contains the same liraglutide active ingredient at the same concentration (6mg/mL) as Saxenda. As a Glenmark-manufactured equivalent, it delivers the same clinical weight loss outcomes at a substantially lower price.
Q5: Can I use Lirafit for diabetes instead of weight loss?
Yes. At 1.2mg or 1.8mg once daily, liraglutide (equivalent to Victoza) is an approved treatment for type 2 diabetes. Your prescriber will determine the appropriate dose based on your glycaemic targets and response.
Customer Reviews
FirstCare Clinic
Canada · 3 months ago
“Good value for bulk procurement orders. Communication was clear and the shipment arrived within the estimated timeframe.”
Dr. Maria Santos
Australia · 3 weeks ago
“Good quality product. Shipping was fast and handled with care. Would recommend for professional hospital procurement.”
Michael K.
USA · 2 months ago
“Fast international shipping and professional packaging. Product was exactly as described. Highly recommend this supplier.”
Dr. James Wilson
USA · 1 week ago
“Excellent product quality. Arrived well-packaged with proper cold chain maintained throughout transit. Will order again.”
Priya Sharma
India · 1 month ago
“Prompt response from the team and smooth ordering process. Medicine arrived in original sealed packaging as expected.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.